Optum Rx increases reimbursement on brand drugs for 2,300 community and independent pharmacies

Building on our March announcement committing to modernize pharmacy payment models, Optum Rx has increased reimbursement minimums for brand drugs for approximately 2,300 independent pharmacies - those not affiliated with a pharmacy services administrative organization (PSAO), chain or other entity - across the country. This move, which went into effect on September 1, 2025, will support the long-term sustainability of pharmacies, which play a critical role in patient care.

This is the latest announcement from Optum Rx, which continues to expand on initiatives to transform how pharmacies are reimbursed for drugs. Optum Rx first launched improved reimbursement earlier this year, with Epic Pharmacy Network, a PSAO representing more than 1,000 independent pharmacies, being the first PSAO to partner with us.

Why it matters

Optum Rx is making this investment to support the long-term sustainability of pharmacies - especially independents that serve vulnerable communities without the scale or resources of larger entities. As brand drug utilization continues to grow alongside manufacturer-set prices, this positive change will help ensure that prescriptions filled by independent pharmacies are reimbursed at a positive margin. Combined, these moves make Optum Rx the first comprehensive, transparent pharmacy services company that passes through savings to its clients and consumers.

What's next

In addition to our commitments to independent pharmacies, we also continue to improve reimbursement for in-network pharmacies, with approximately 24,000 retail community pharmacies eligible for increased reimbursement through our Independent Pharmacy Network.

Learn more about Optum Rx's commitments here.